Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experien… (NCT01872715) | Clinical Trial Compass
CompletedPhase 4
Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea
United States24 participantsStarted 2013-03
Plain-language summary
The purpose of this study is to characterize rosacea patients', being treated with Oracea, perception through visual analog scale reporting.
Who can participate
Age range25 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Men and women
* 25-70 years
* Diagnosis of papulopustular rosacea
* Eligible for Oracea treatment
Exclusion Criteria:
* Allergies to components of investigational product and/or hypersensitivity to tetracyclines
* Taken systemic therapy directed at improving rosacea, including antibiotics, within 30 days prior to baseline visit
* Used topical rosacea treatment within 30 days prior to baseline visit
* Have active ocular rosacea and/or blepharitis/meibomianitis requiring systemic treatment by an opthalmologist
* Previously failed to have improvement of rosacea with appropriate use of systemic tetracycline family of antibiotics
* Exposed to intense/excessive ultraviolet (UV) radiation within one week prior to baseline and/or who forsee unprotected and intense/excessive UV exposure during the course of the study
* Have planned surgical procedures during the course of the study
* Have used tetracycline antibiotics within 30 days prior to baseline visit or during study
* At risk in terms of precautions, warnings, and contraindications